Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Experimental and Clinical Psychopharmacology
|
February 24, 2011
A multimodal approach to assessing the impact of nicotine dependence, nicotine abstinence, and craving on negative affect in smokers
Jason D Robinson, Cho Y Lam, Brian L Carter, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 22, 2016
Attentional bias to smoking and other motivationally relevant cues is affected by nicotine exposure and dose expectancy
Jason D Robinson, Francesco Versace, Jeffery M Engelmann, et al.
Drug and Alcohol Dependence
|
June 15, 2025
The late positive potential predicts contingency management outcomes for cocaine use disorder
Heather E Webber, Douglas J Calvillo, Francesco Versace, et al.
Psychophysiology
|
January 15, 2010
Cigarette cues capture smokers' attention: evidence from event-related potentials
Francesco Versace, Jason D Robinson, Cho Y Lam, et al.
Psychopharmacology
|
March 10, 2017
Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment
Paul M Cinciripini, Charles E Green, Jason D Robinson, et al.
BMJ Open
|
May 20, 2026
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial
Luba Yammine, Francesco Versace, Charles E Green, et al.
JAMA Psychiatry
|
March 29, 2013
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal
Paul M Cinciripini, Jason D Robinson, Maher Karam-Hage, et al.
Addiction (Abingdon, England)
|
April 22, 2018
An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use
Paul M Cinciripini, Jennifer A Minnix, Charles E Green, et al.
Addiction (Abingdon, England)
|
February 20, 2026
Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial
Francesco Versace, Charles E Green, Yong Cui, et al.
Experimental and Clinical Psychopharmacology
|
December 8, 2022
Assessing cocaine motivational value: Comparison of brain reactivity bias toward cocaine cues and cocaine demand
Heather E Webber, Jin H Yoon, Constanza de Dios, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Experimental and Clinical Psychopharmacology
|
February 24, 2011
A multimodal approach to assessing the impact of nicotine dependence, nicotine abstinence, and craving on negative affect in smokers
Jason D Robinson, Cho Y Lam, Brian L Carter, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 22, 2016
Attentional bias to smoking and other motivationally relevant cues is affected by nicotine exposure and dose expectancy
Jason D Robinson, Francesco Versace, Jeffery M Engelmann, et al.
Drug and Alcohol Dependence
|
June 15, 2025
The late positive potential predicts contingency management outcomes for cocaine use disorder
Heather E Webber, Douglas J Calvillo, Francesco Versace, et al.
Psychophysiology
|
January 15, 2010
Cigarette cues capture smokers' attention: evidence from event-related potentials
Francesco Versace, Jason D Robinson, Cho Y Lam, et al.
Psychopharmacology
|
March 10, 2017
Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment
Paul M Cinciripini, Charles E Green, Jason D Robinson, et al.
BMJ Open
|
May 20, 2026
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial
Luba Yammine, Francesco Versace, Charles E Green, et al.
JAMA Psychiatry
|
March 29, 2013
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal
Paul M Cinciripini, Jason D Robinson, Maher Karam-Hage, et al.
Addiction (Abingdon, England)
|
April 22, 2018
An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use
Paul M Cinciripini, Jennifer A Minnix, Charles E Green, et al.
Addiction (Abingdon, England)
|
February 20, 2026
Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial
Francesco Versace, Charles E Green, Yong Cui, et al.
Experimental and Clinical Psychopharmacology
|
December 8, 2022
Assessing cocaine motivational value: Comparison of brain reactivity bias toward cocaine cues and cocaine demand
Heather E Webber, Jin H Yoon, Constanza de Dios, et al.
Page
of 8